Dutch gout patients' perspective on continuation or discontinuation of urate-lowering therapy during remission: a mixed methods study.

These results can aid shared decision making and provide input for what's important to discuss with gout patients in remission, when they consider ULT discontinuation. Emphasis should be on the risk of having gout flares and joint damage, not so much on facilitating how easily medication is received.